Chronic lymphocytic leukemia has been the subject of sustained clinical investigation across multiple research sites.

43 total trials for this combination

Showing top 10 of 43 trials

Trials

NCT ID	Title	Status	Phase
NCT04965493	A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)	ACTIVE_NOT_RECRUITING	PHASE3
NCT06973187	A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma	RECRUITING	—
NCT02952508	Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia	ACTIVE_NOT_RECRUITING	PHASE2
NCT05334069	Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection	RECRUITING	—
NCT00898079	Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer	COMPLETED	—
NCT03701282	Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia	ACTIVE_NOT_RECRUITING	PHASE3
NCT03737981	Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia	ACTIVE_NOT_RECRUITING	PHASE3
NCT01300026	AMG 319 Lymphoid Malignancy FIH	COMPLETED	PHASE1
NCT04269902	Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study	RECRUITING	—
NCT04269902	Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study	RECRUITING	—

Related Pages

All Chronic lymphocytic leukemia trials All trials in Durham, United States